TY  - GEN 
AU  - Rojo Tolosa, Susana
AU  - Pineda Lancheros, Laura Elena
AU  - Gálvez Navas, José María
AU  - Pérez Ramírez, Cristina
PY  - 2023
UR  - https://hdl.handle.net/10481/82313
AB  - Omalizumab is a monoclonal antibody indicated for the treatment of severe uncontrolled
asthma with an allergic phenotype. Its effectiveness could be influenced by clinical variables and
single nucleotide polymorphisms (SNPs) in one or more of the...
LA  - eng
PB  - MDPI
KW  - Severe uncontrolled asthma
KW  - Omalizumab
KW  - Effectiveness
KW  - Polymorphism
TI  - Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic Phenotype
DO  - 10.3390/ijms24087029
ER  -